From: Lung function and radiological findings 1 year after COVID-19: a prospective follow-up
Total N | Missing | Univariable analysis | Multivariable analysis n = 144 | |||
---|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |||
Age, years | 283 | 1 | 1.02 (1.00–1.04) | 0.01 | 1.04 (1.00–1.07) | 0.013 |
Female sex | 284 | 0 | 2.53 (1.56–4.14) | 0.001 | 6.22 (2.77–15.04) | 0.001 |
BMI, kg/m2 | 278 | 6 | 0.98 (0.93–1.03) | 0.48 | 0.91 (0.84–0.99) | 0.036 |
Smoker | 283 | 1 | 1.48 (0.91–2.43) | 0.11 | N/A | N/A |
Pulmonary disease | 284 | 0 | 0.66 (0.34–1.25) | 0.21 | N/A | N/A |
Hypertension | 284 | 0 | 1.02 (0.63–1.66) | 0.91 | N/A | N/A |
Diabetes | 284 | 0 | 1.08 (0.54–2.11) | 0.81 | N/A | N/A |
Cardiovascular disease | 284 | 0 | 2.18 (0.99–4.91) | 0.05 | NA | NA |
Admission RALE score | 278 | 6 | 1.08 (0.94–1.25) | 0.24 | N/A | N/A |
Peak RALE score | 278 | 6 | 1.07 (0.94–1.21) | 0.25 | N/A | N/A |
Length of hospital stay, days | 280 | 4 | 1.01 (1.00–1.03) | 0.01 | NA | NA |
Lymphocytesa, × 109/L | 240 | 44 | 0.84 (0.49–1.40) | 0.51 | N/A | N/A |
LDH, U/L | 241 | 43 | 1.00 (1.00–1.01) | 0.02 | NA | NA |
C-reactive protein, mg/L | 249 | 35 | 1.00 (0.99–1.00) | 0.14 | N/A | N/A |
Ferritin, ng/mL | 204 | 80 | 1.00 (0.99–1.00) | 0.15 | 1.00 (1.00–1.01) | 0.008 |
Fibrinogen, g/L | 178 | 106 | 1.07 (1.00–1.27) | 0.39 | 1.02 (0.99–1.26) | 0.79 |
D-dimer, ng/mL | 252 | 32 | 1.00 (1.00–1.01) | 0.01 | 1.00 (1.00–1.01) | 0.07 |
Severity group 3 | 284 | 0 | 2.25 (1.22–4.20) | 0.009 | 1.05 (0.33–3.33) | NA |